(1)
Kubica, K.; Mazurek, A. VEMURAFENIB AS A SELECTIVE INHIBITOR OF THE SERINE/THREONINE-PROTEIN KINASE B-RAF, USED IN THE TREATMENT OF MELANOMA. Prosp. Pharm. Sc. 2016, 14, 52-56.